Live Breaking News & Updates on Data Encouraging Solid Biosciences

Stay updated with breaking news from Data encouraging solid biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DMD | Benzinga

Just weeks into its life as a publicly traded company, Solid Biosciences Inc (NASDAQ: SLDB) caught the eyes of four analysts who assumed coverage Tuesday with a mix of Holds and Buys.
Here is what one of the more bearish critics had to say.
The Rating
Goldman Sachs analyst Salveen Richter. Read More. ....

Adam Feuerstein , Goldman Sachs , Yun Zhong , Pharma Emflaza , Debjit Chattopadhyay , Sarepta Exondys , Leerink Joseph Schwartz , Alethia Young , Brian Abrahams , Salveen Richter , Joseph Schwartz , Doug Ingram , Goldman Sachs Gets Firm On Solid Biosciencestuesday , Why Wave Life Sciences Valuation Is Falling , Wave Life Sciences Ltd , Credit Suisse , Drug Administration , Marathon Pharmaceuticals , Sarepta Therapeutics Inc , Solid Biosciences Inc , Health Care , Wave Life Sciences , Duchenne Muscular Dystrophy , Dosing Of Sarepta , Next Gen Eteplirsen Can Potentially Achieve Over , Therapeutics Inc ,

Duchenne Muscular Dystrophy

Roche Holdings AG Basel ADR (OTC: RHHBY) said Monday that it has signed a licensing agreement with Sarepta Therapeutics Inc (NASDAQ: SRPT) to acquire the commercial rights to the latter s investigational gene therapy asset SRP-9001 outside of the U.S. The asset is being evaluated in. Read More. ....

United Kingdom , Debjit Chattopadhyay , Gbola Amusa , Morgan Stanley Matthew Harrison , Martin Auster , Brian Abrahams , Sarepta Progressmonday , Morgan Stanley , Why Wave Life Sciences Valuation Is Falling , Gene Therapy Program On Holdtuesday , Roche Partnership Derisks Sarepta Investor Concernstuesday , Wave Life Sciences Ltd , Credit Suisse , Drug Administration , Therapeutics Inc , Roche Holdings Ag Basel , Sarepta Therapeutics Inc , Solid Biosciences Inc , Health Care , Wave Life Sciences , Duchenne Muscular Dystrophy , Dosing Of Sarepta , Next Gen Eteplirsen Can Potentially Achieve Over , Biosciences Inc , Data Encouraging Solid Biosciences , Analyst Projects ,